Tara L. Gonzales, MD
Vice President, Medical Affairs
Veru, Inc
Pensacola, Florida, United States
Disclosure: Disclosure(s): Veru Inc.: Employee ()
Paula Skarda, MD (she/her/hers)
Hospitalist, Regions Hospital
Regions Hospital
St. Paul, MN, United States
Disclosure: Disclosure(s): No financial relationships to disclose
Thomas G. Bird, Ph.D.
Executive Vice President
Veru Inc
Eads, Tennessee, United States
Disclosure: Disclosure(s): No financial relationships to disclose
Michael Schnaus, MD
MD
HealthPartners
St. Paul, Minnesota, United States
Disclosure: Disclosure(s): No financial relationships to disclose
Mitchell Steiner, MD
CEO
Veru, Inc
Miami, Florida, United States
Disclosure: Disclosure(s): Veru, Inc: Board Member (), Stocks/Bonds ()
Alan Skolnick, MD
HD Research
Houston, Texas, United States
Disclosure: Disclosure(s): No financial relationships to disclose
K. Gary Barnette, PhD
Veru Inc.
Miami, Florida, United States
Disclosure: Disclosure(s): Veru Inc.: Employee (), Ownership Interest ()
Michael S. Gordon, MD
Chief Medical Officer
HonorHealth Research Institute
Scottsdale, Arizona, United States
Disclosure: Disclosure(s): Agenus: Grant/Research Support (); Arcus: Grant/Research Support (); Astex: Grant/Research Support (); ATEA: Grant/Research Support (); Beigene: Grant/Research Support (); Caremission: Ownership Interest (); Celldex: Grant/Research Support (); Corcept: Grant/Research Support (); Daiichi: Grant/Research Support (); Deciphera: Grant/Research Support (); Endocyte: Grant/Research Support (); Forma: Grant/Research Support (); FujiFilm: Grant/Research Support (); Genentech/Roche: Grant/Research Support (); I-MAB Pharma: Grant/Research Support (); Imaginab: Advisor/Consultant (), Grant/Research Support (); Imaging Endpoints: Advisor/Consultant (); Incyte: Grant/Research Support (); Kinevant: Grant/Research Support (); Medelis: Ownership Interest (); Medimmune: Grant/Research Support (); Morphic Tx: Advisor/Consultant (); Nikang: Grant/Research Support (); OncoResponse: Grant/Research Support (); OnQuality: Advisor/Consultant (); Pfizer: Advisor/Consultant (), Grant/Research Support (); Pionyr: Grant/Research Support (); Plexxicon: Grant/Research Support (); Qualigen: Advisor/Consultant (); RedHill Bio: Grant/Research Support (); Revolution Medicine: Grant/Research Support (); Riboscience: Grant/Research Support (); Seattle Genetics: Grant/Research Support (); Serono: Grant/Research Support (); SQZ Biotech: Grant/Research Support (); Syndax: Grant/Research Support (); Theseus: Grant/Research Support (); Tolero: Grant/Research Support (); Tracon: Grant/Research Support (); Vedanta: Grant/Research Support (); Veru: Grant/Research Support ()
Eduardo Sprinz, MD; MsC, ScD
Hospital de Clinicas de Porto Alegre - UFRGS
Porto Alegre, Rio Grande do Sul, Brazil
Disclosure: Disclosure(s): Gilead: Advisor/Consultant (), Board Member (); GSK: Advisor/Consultant (), Board Member (), Grant/Research Support (), Honoraria (); Janssen: Advisor/Consultant (), Board Member (), Honoraria ()
Domingo Rodriguez, n/a
Veru Inc
Miami, Florida, United States
Disclosure: Disclosure(s): Veru: Stocks/Bonds ()
Petar Kalaydzhiev, MD
University Multiprofile Hospital for Active Treatment ”Tsaritsa Yoanna-ISUL” EAD, Sofia
Sofia, Sofiya, Bulgaria
Disclosure: Disclosure(s): No financial relationships to disclose
Georgi Arabadzhiev, MD, PhD
University Multiprofile Hospital for Active Treatment
Stara Zagora, Stara Zagora, Bulgaria
Disclosure: Disclosure(s): No financial relationships to disclose